top of page

MABTHERA SOLUTION FOR SUBCUTANEOUS INJECTION 1400MG

Product details

Registration number: SIN15023P

Classification: Prescription Only

Active ingredients: Rituximab

Strength: 1400mg

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Registrant: ROCHE SINGAPORE PTE. LTD.

ATC code: L01XC02

HSA approval date: 1 June 2016

Manufacturer(s): F. Hoffmann-La Roche Ltd

Manufacturing country/countries: SWITZERLAND

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page